AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 4mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Dibaglim M 4mg/500mg Tablet SR

Glyciphage M 4mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Dibaglim M 4mg/500mg Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Dibaglim M 4mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Dibaglim M 4mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dibaglim M 4mg/500mg Tablet SR whole; do not chew, crush, or fracture it. Administer this medication with a meal.

Common Side effects of Dibaglim M 4mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 4mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dibaglim M 4mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.

How Dibaglim M 4mg/500mg Tablet SR works:

Dibaglim M 4mg/500mg sustained-release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Dibaglim M 4mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dibaglim M 4mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Dibaglim M 4mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Dibaglim M 4mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dibaglim M 4mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiating treatment with a low dose of Dibaglim M 4mg/500mg Tablet SR is typical; however, it's contraindicated in cases of severe liver disease.

What if you forget to take Dibaglim M 4mg/500mg Tablet SR :

Should you forget a dose of Dibaglim M 4mg/500mg sustained-release tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 4mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Dibaglim M 4mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Dibaglim M 4mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Dibaglim M 4mg/500mg Tablet SR and seek immediate medical attention.
Dibaglim M 4mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Dibaglim M 4mg/500mg SR Tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 4mg/500mg SR tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Dibaglim M 4mg/500mg SR tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dibaglim M 4mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the medication's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Dibaglim M 4mg/500mg Tabl...
82
MRP 100
18% off